Evidence map›Paper›PMID 33868630›Full record

ArticleParkinson's disease2021

Use of a Smartphone to Gather Parkinson's Disease Neurological Vital Signs during the COVID-19 Pandemic.

Jay L Alberts, Mandy Miller Koop, Marisa P McGinley, Amanda L Penko, Hubert H Fernandez, Steven Shook, Robert A Bermel, André Machado, Anson B Rosenfeldt

Open access · goldAbstract read
In one paragraph

Article in Parkinson's disease, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
1.9field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 19 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Jay L AlbertsCleveland Clinic, Lerner Research Institute, Department of Biomedical Engineering, Cleveland, OH, USA.ORCID https://orcid.org/0000-0002-9379-3630
Mandy Miller KoopCleveland Clinic, Lerner Research Institute, Department of Biomedical Engineering, Cleveland, OH, USA.ORCID https://orcid.org/0000-0003-3047-8091
Marisa P McGinleyCleveland Clinic, Neurological Institute, Mellen Center for Multiple Sclerosis, Cleveland, OH, USA.ORCID https://orcid.org/0000-0002-7463-6787
Amanda L PenkoCleveland Clinic, Lerner Research Institute, Department of Biomedical Engineering, Cleveland, OH, USA.ORCID https://orcid.org/0000-0003-1750-4240
Hubert H FernandezCleveland Clinic, Neurological Institute, Center for Neurological Restoration, Cleveland, OH, USA.ORCID https://orcid.org/0000-0002-8553-5316
Steven ShookCleveland Clinic, Neurological Institute, Center for Neurological Restoration, Cleveland, OH, USA.ORCID https://orcid.org/0000-0001-7244-6878
Robert A BermelCleveland Clinic, Neurological Institute, Mellen Center for Multiple Sclerosis, Cleveland, OH, USA.ORCID https://orcid.org/0000-0003-2334-6883
André MachadoCleveland Clinic, Neurological Institute, Center for Neurological Restoration, Cleveland, OH, USA.ORCID https://orcid.org/0000-0002-5945-7190
Anson B RosenfeldtCleveland Clinic, Lerner Research Institute, Department of Biomedical Engineering, Cleveland, OH, USA.ORCID https://orcid.org/0000-0001-5468-8208
Cleveland Clinic · USCleveland Clinic Lerner College of Medicine · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionTo overcome travel restrictions during the COVID-19 pandemic, consumer-based technology was rapidly deployed to the smartphones of individuals with Parkinson's disease (PD) participating in a 12-month exercise trial. The aim of the project was to determine the feasibility of utilizing a combined synchronous and asynchronous self-administered smartphone application to characterize PD symptoms.

methodsA synchronous video virtual visit was completed for the administration of virtual Movement Disorder Society-Unified Parkinson's Disease Rating Scale III (vMDS-UPDRS III). Participants asynchronously completed a mobile application consisting of a measure of upper extremity bradykinesia (Finger Tapping Test) and information processing.

resultsTwenty-three individuals completed the assessments. The mean vMDS-UPDRS III was 23.65 ± 8.56 points. On average, the number of taps was significantly greater for the less affected limb, 97.96 ± 17.77 taps, compared to the more affected, 89.33 ± 18.66 taps (

Identifiers

PMID33868630
PMCPMC8035908
OpenAlexW3154092549

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.